SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ENZON, Inc. - New Chairman
ENZN 0.04000.0%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ed who wrote (17)4/1/1997 8:40:00 PM
From: GC   of 96
 
Ed,

I only know what was already released. Last 7 insider
tranactions were all buys. Not a lot of stock though. I did
talk to the company recently and was told that virtually every
employee is a shareholder and the company is now working on
getting some visibility in the investment community. Up to now
I don't think they cared if anyone knew what they are up to. By
the way, if they don't get stock price up soon, they are going
to get bought out, probably by Green Cross. That is my opinion.
It is based on the royalties on a 400 million dollar drug. I can't
confirm because the company is SO tight lipped about their agreements
etc., but was stated on AOL message board that royalty is 20%. If
that is true, they will be bought out for sure as even 10.00 a share
would give Green Cross all of ENZN for just 3-5 years royalty on rHSA.
It should be approved late next year and the royalties would last until 2013. Green Cross was bought by some bigger Japanese Co. and
I'm sure they are looking at ENZN right now. IT IS JUST TOO DARN
CHEAP and it won't be for long. Regards.

Gary
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext